Irit Arbel
CIK: 0001245607
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Director
Discretionary Trading P&L
Holdings
About ARBEL IRIT
ARBEL IRIT (SEC CIK 0001245607) files insider reports with the SEC as Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 2 ownership filings by ARBEL IRIT, all Form 4s, filed between Jan 3, 2025 and May 29, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ARBEL IRIT's filings is in NEW YORK, NY.
Recent filings by ARBEL IRIT
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- Bairu Menghisteab, Director